Does LISOCABTAGENE MARALEUCEL Cause Neurotoxicity? 101 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 101 reports of Neurotoxicity have been filed in association with LISOCABTAGENE MARALEUCEL (BREYANZI). This represents 13.7% of all adverse event reports for LISOCABTAGENE MARALEUCEL.
101
Reports of Neurotoxicity with LISOCABTAGENE MARALEUCEL
13.7%
of all LISOCABTAGENE MARALEUCEL reports
7
Deaths
68
Hospitalizations
How Dangerous Is Neurotoxicity From LISOCABTAGENE MARALEUCEL?
Of the 101 reports, 7 (6.9%) resulted in death, 68 (67.3%) required hospitalization, and 5 (5.0%) were considered life-threatening.
Is Neurotoxicity Listed in the Official Label?
Yes, Neurotoxicity is listed as a known adverse reaction in the official FDA drug label for LISOCABTAGENE MARALEUCEL.
What Other Side Effects Does LISOCABTAGENE MARALEUCEL Cause?
Cytokine release syndrome (315)
Immune effector cell-associated neurotoxicity syndrome (129)
Pyrexia (47)
Fatigue (38)
Hypotension (38)
Febrile neutropenia (28)
Confusional state (27)
Death (25)
Lymphocyte adoptive therapy (25)
Malignant neoplasm progression (23)
What Other Drugs Cause Neurotoxicity?
AXICABTAGENE CILOLEUCEL (1,327)
OXALIPLATIN (1,272)
METHOTREXATE (1,083)
CYCLOPHOSPHAMIDE (763)
FLUOROURACIL (735)
PACLITAXEL (734)
TACROLIMUS (623)
BEVACIZUMAB (588)
VINCRISTINE (555)
CAPECITABINE (553)
Which LISOCABTAGENE MARALEUCEL Alternatives Have Lower Neurotoxicity Risk?
LISOCABTAGENE MARALEUCEL vs LITHIUM
LISOCABTAGENE MARALEUCEL vs LIXISENATIDE
LISOCABTAGENE MARALEUCEL vs LOBAPLATIN
LISOCABTAGENE MARALEUCEL vs LOFEXIDINE
LISOCABTAGENE MARALEUCEL vs LOMITAPIDE